Refreshing results…
Histone H1 loss drives lymphoma by disrupting 3D chromatin architecture
Download from www.nature.comHDAC Inhibition Enhances the In Vivo Efficacy of MEK Inhibitor Therapy in Uveal Melanoma
UploadMissing publications? Search for publications with a matching author name.